Showing results (31-40 of 96) with videos related to
Sort By:
Pageof 10
Recenti Progressi in Medicina|March 22, 2022
Chronic treatment of COPD: state of the art and real-world analysis of healthcare costs based on medication adherence dataAnna Stella Lonigro, Domenica Ancona, Antonella Liantonio, et al.Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|January 3, 2025
Dapagliflozin ameliorates Lafora disease phenotype in a zebrafish modelStefania Della Vecchia, Paola Imbrici, Antonella Liantonio, et al.Experimental Neurology|May 15, 2021
Increased sarcolemma chloride conductance as one of the mechanisms of action of carbonic anhydrase inhibitors in muscle excitability disordersConcetta Altamura, Adriano Fonzino, Nancy Tarantino, et al.The Journal of Physiology|September 15, 2007
Disuse of rat muscle in vivo reduces protein kinase C activity controlling the sarcolemma chloride conductanceSabata Pierno, Jean-François Desaphy, Antonella Liantonio, et al.Biomedicines|August 26, 2023
Brugada Syndrome: More than a Monogenic ChannelopathyAntonella Liantonio, Matteo Bertini, Antonietta Mele, et al.Frontiers in Pharmacology|July 25, 2025
Adverse effects of antiseizure medications: a review of the impact of pharmacogenetics and drugs interactions in clinical practiceMichela De Bellis, Giuseppe d'Orsi, Egidio Maria Rubino, et al.Endocrinology|July 10, 2013
Growth hormone secretagogues exert differential effects on skeletal muscle calcium homeostasis in male rats depending on the peptidyl/nonpeptidyl structureAntonella Liantonio, Gianluca Gramegna, Giuseppe Carbonara, et al.Epileptic Disorders : International Epilepsy Journal with Videotape|February 20, 2026
Expanding the phenotypic spectrum of CACNA1A-related developmental and epileptic encephalopathy in adultsOrazio Palumbo, Umberto Costantino, Mario Benvenuto, et al.International Journal of Molecular Sciences|September 28, 2021
A Novel <i>KCNA2</i> Variant in a Patient with Non-Progressive Congenital Ataxia and Epilepsy: Functional Characterization and Sensitivity to 4-AminopyridinePaola Imbrici, Elena Conte, Rikard Blunck, et al.Journal of the American Society of Nephrology : JASN|December 25, 2003
Investigations of pharmacologic properties of the renal CLC-K1 chloride channel co-expressed with barttin by the use of 2-(p-Chlorophenoxy)propionic acid derivatives and other structurally unrelated chloride channels blockersAntonella Liantonio, Michael Pusch, Alessandra Picollo, et al.Pageof 10